Market Cap 257.25M
Revenue (ttm) 0.00
Net Income (ttm) -47.05M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.73
Volume 247,400
Avg Vol 537,594
Day's Range N/A - N/A
Shares Out 64.47M
Stochastic %K 14%
Beta 0.95
Analysts Sell
Price Target $11.00

Company Profile

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in Phase 2b/3 clinical trial to prevent esophageal varices in patient with non-alcoholic steatohepatitis cirrhosis; and Phase 2 clinical trial for the treatment of liver fibrosis, as well as severe skin disease, and melanoma and he...

Industry: Biotechnology
Sector: Healthcare
Phone: 678 620 3186
Address:
4960 Peachtree Industrial Boulevard, Suite 240, Norcross, United States
BIGT80
BIGT80 Dec. 25 at 10:00 PM
$GALT this will be my last post on this board until I buy back my shares for lower, which I’m hoping I get the opportunity to do. This board hates anyone with differing opinion on just blindly holding so kind of no reason to go back and forth. Good luck bulls mostly. I’ve never shorted this and never will so hard to love the bears. See ya all in 30-60 days!
0 · Reply
BIGT80
BIGT80 Dec. 25 at 9:56 PM
$GALT for the record I have no known metal illness! I’m simply here to have some fun!
0 · Reply
D_Coral
D_Coral Dec. 25 at 9:38 PM
$GALT This BIGT character has some kind of mental illness. He goes from slamming the board with boobs, to making FALSE statements about people. For the record his statements are 100% lies. BIGT will be liable for libel and defamation.
1 · Reply
BIGT80
BIGT80 Dec. 25 at 9:32 PM
$GALT just so everyone knows there are some folks here that are now calling insiders like Joel Lewis and other directors who have sold and rebought later swing traders. The CEO according to these folks mainly @D_Coral whom we all know runs 6 accounts on this board!
1 · Reply
BIGT80
BIGT80 Dec. 25 at 9:15 PM
$GALT Swing trading involves holding a position for several days to a few weeks to profit from price "swings" within a larger trend, which differs from traditional long-term investing where shares are held for years. It is possible to combine both strategies, but they serve different financial goals and require separate management to avoid conflicts. By definition like it or not I am not a swing trader. Nearly 90% of th shares that I sold were long. That means I held for at least 1 year. My strategy paid off so far. Does it mean I will miss the next run up? Maybe, but my DD and logic says I get the opportunity to buy some or all shares back for less than I paid. I’m not hiding my strategy or approach so stop acting like I am!
1 · Reply
Plantimal
Plantimal Dec. 25 at 9:12 PM
$GALT Wow good stuff
0 · Reply
BIGT80
BIGT80 Dec. 25 at 8:58 PM
$GALT I think some handles on here are angry because they done know how to sell for profit. Even insiders know that sometimes you have to sell to make a profit. I guess if I were like @D_Coral i would be upset after holding this for over a decade and never making a penny, while I and many others lie the CEO and directors cash in our millions!!!
0 · Reply
MoneyInc
MoneyInc Dec. 25 at 8:57 PM
0 · Reply
Icemanrush16
Icemanrush16 Dec. 25 at 8:47 PM
$GALT been in this ticker for a week now - wholly cow it trades tight since the drop - feels like a tug of war between two equal teams - ready to see who pulls the hardest
1 · Reply
ThomasLD
ThomasLD Dec. 25 at 8:38 PM
$GALT Why did you block @D_Coral and against @Scarlivertriumphant ‘ best post today over Christmas Holiday? You are piece of trash.
2 · Reply
Latest News on GALT
Galectin Therapeutics to Present in Upcoming Conferences

Oct 14, 2022, 8:00 AM EDT - 3 years ago

Galectin Therapeutics to Present in Upcoming Conferences


Galectin: Ability To Potentially Target Unmet Medical Need

Jul 11, 2022, 4:16 PM EDT - 3 years ago

Galectin: Ability To Potentially Target Unmet Medical Need


BIGT80
BIGT80 Dec. 25 at 10:00 PM
$GALT this will be my last post on this board until I buy back my shares for lower, which I’m hoping I get the opportunity to do. This board hates anyone with differing opinion on just blindly holding so kind of no reason to go back and forth. Good luck bulls mostly. I’ve never shorted this and never will so hard to love the bears. See ya all in 30-60 days!
0 · Reply
BIGT80
BIGT80 Dec. 25 at 9:56 PM
$GALT for the record I have no known metal illness! I’m simply here to have some fun!
0 · Reply
D_Coral
D_Coral Dec. 25 at 9:38 PM
$GALT This BIGT character has some kind of mental illness. He goes from slamming the board with boobs, to making FALSE statements about people. For the record his statements are 100% lies. BIGT will be liable for libel and defamation.
1 · Reply
BIGT80
BIGT80 Dec. 25 at 9:32 PM
$GALT just so everyone knows there are some folks here that are now calling insiders like Joel Lewis and other directors who have sold and rebought later swing traders. The CEO according to these folks mainly @D_Coral whom we all know runs 6 accounts on this board!
1 · Reply
BIGT80
BIGT80 Dec. 25 at 9:15 PM
$GALT Swing trading involves holding a position for several days to a few weeks to profit from price "swings" within a larger trend, which differs from traditional long-term investing where shares are held for years. It is possible to combine both strategies, but they serve different financial goals and require separate management to avoid conflicts. By definition like it or not I am not a swing trader. Nearly 90% of th shares that I sold were long. That means I held for at least 1 year. My strategy paid off so far. Does it mean I will miss the next run up? Maybe, but my DD and logic says I get the opportunity to buy some or all shares back for less than I paid. I’m not hiding my strategy or approach so stop acting like I am!
1 · Reply
Plantimal
Plantimal Dec. 25 at 9:12 PM
$GALT Wow good stuff
0 · Reply
BIGT80
BIGT80 Dec. 25 at 8:58 PM
$GALT I think some handles on here are angry because they done know how to sell for profit. Even insiders know that sometimes you have to sell to make a profit. I guess if I were like @D_Coral i would be upset after holding this for over a decade and never making a penny, while I and many others lie the CEO and directors cash in our millions!!!
0 · Reply
MoneyInc
MoneyInc Dec. 25 at 8:57 PM
0 · Reply
Icemanrush16
Icemanrush16 Dec. 25 at 8:47 PM
$GALT been in this ticker for a week now - wholly cow it trades tight since the drop - feels like a tug of war between two equal teams - ready to see who pulls the hardest
1 · Reply
ThomasLD
ThomasLD Dec. 25 at 8:38 PM
$GALT Why did you block @D_Coral and against @Scarlivertriumphant ‘ best post today over Christmas Holiday? You are piece of trash.
2 · Reply
BIGT80
BIGT80 Dec. 25 at 8:30 PM
$GALT look at the Christmas anger spewing off DCoral!
0 · Reply
D_Coral
D_Coral Dec. 25 at 7:48 PM
$GALT It is interesting to see what Google Gemini AI thinks about GALT partnership/buyout probabilities at various points in 2026:
1 · Reply
Boellie
Boellie Dec. 25 at 7:37 PM
0 · Reply
BIGT80
BIGT80 Dec. 25 at 6:04 PM
$GALT scarliver gave a bad example of an approved drug that our CMO was a part of: Terlivaz carries a Boxed Warning because it may cause serious or fatal respiratory failure. Patients at higher risk include those with volume overload or acute-on-chronic liver failure (ACLF) Grade 3. Careful to everyone for the information all of us post. Ensure you do your own DD. Owning a stock like Galectin is not for the faint of heart!
3 · Reply
JBRUN
JBRUN Dec. 25 at 6:02 PM
$AUPH $GALT Merry Christmas! Happy Holidays!
0 · Reply
SpectralDelta
SpectralDelta Dec. 25 at 3:04 PM
$GALT biotech sleeper low attention needs volume
0 · Reply
Scarlivertriumphant
Scarlivertriumphant Dec. 25 at 1:42 PM
$GALT In September 2022 the FDA approved Terlivaz for Hepatorenal Syndrome. Our Chief Medical Officer, Khurram Jamil, took this late-stage drug through the FDA approval process. He has also chaired FDA advisory committee meetings on liver drugs. I believe we are in excellent hands with our CMO and have to believe that he is huddling with outside consultants on a strategy for the Type C face to face meeting. I also believe that it would be unethical for the FDA to wait five more years here. I see accelerated approval coming and a Big Pharma conducting a confirmatory P3. Good luck
1 · Reply
Scarlivertriumphant
Scarlivertriumphant Dec. 25 at 11:57 AM
$GALT A wonderful Christmas Holiday for everyone. Appears that the stock has stabilized. Upcoming events include the Type C FDA meeting with our KOLs (?plural), peer reviewed publications (? plural) in major journals. Also note that the deadline for EASL abstract submission is January 5, and I have to believe they are working on something for the European meetings. Our CEO said additional investigations of NAVIGATE are ongoing. I never saw the CTX III (fibrinolysis) data from Nordic Biosciences. Was that data saved for EASL? This company is very much alive. I'm not paid by any entity, just a long-time investor who finds this Galectin 3 inhibition story fascinating. Good luck to everyone.
3 · Reply
SmartOptionsAlert
SmartOptionsAlert Dec. 25 at 9:15 AM
🔎 $GALT Options Scan Update (03:15 CT) No standout unusual options activity right now. Bias: Neutral • Waiting for stronger flow https://smartoptions.ai
0 · Reply
Indibviduate1
Indibviduate1 Dec. 25 at 7:25 AM
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 25 at 7:14 AM
Enter: $GALT Calls Strike Price: $5 Expiry Date: JAN 16 2026 Buy in Price: $0.08 - $0.15 Sell Price: $0.15 Profit : +87% (Turn every $1 into $1.87) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
Indibviduate1
Indibviduate1 Dec. 25 at 7:12 AM
1 · Reply